Is MYGN up or down today?
MYGN is down 0.33% today, last at 6.02. This stock moved -0.33% versus the prior close.
MYGN · MYGN
MYGN (MYGN) is trading at 6.02, down 0.33% on the session. MYGN sits at the 58% mark of its 52-week range, carries a 14-day RSI of 63, and trades above its 50-day average. Over the past month it is up 40.65%.
Leading the coverage: “MYGN Q3'26 Earnings: revenue estimate is 191.33M USD - TradingView” (Google News Earnings, 7d ago). MYGN is -3.97% since story.
MYGN trades on a trailing P/E of 41.9 and is running 41.69% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
MYGN is down 0.33% today, last at 6.02. This stock moved -0.33% versus the prior close.
Leading the coverage: “MYGN Q3'26 Earnings: revenue estimate is 191.33M USD - TradingView” (Google News Earnings, 7d ago). MYGN is -3.97% since story. Dominant story: Myriad Genetics stock lifts outlook after resilient Q3 performance - ad-hoc-news.de (1 source, neutral) RSI is 63 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Myriad Genetics stock lifts outlook after resilient Q3 performance - ad-hoc-news.de
Myriad Genetics earnings beat by $0.09, revenue topped estimates - Investing.com UK
Myriad Genetics (NASDAQ:MYGN) Q3 Beats Estimates, Raises Guidance, and Strikes Prenatal Sale to Labcorp
Myriad Genetics (MYGN) Reports Q3 Loss, Beats Revenue Estimates
Myriad Genetics (MYGN) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance